An interventional study of Orthosis acceptability in Cerebral Palsy (CP), Brain Injuries and Neuromotor Dysfunction, sponsored by IRCCS Eugenio Medea. Recruiting at 1 site in Italy. Open to participants aged 6 Years to 14 Years. Per ClinicalTrials.gov, last updated 2026-10-06.
Sponsored by IRCCS Eugenio Medea · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 18 studies in Cerebral Palsy by IRCCS Eugenio Medea — 8 open to participants now, 8 under way, none of them phase 3. Cerebral Palsy · IRCCS Eugenio Medea.
Among the 18 studies in Cerebral Palsy by IRCCS Eugenio Medea, this one is the 10th largest by planned enrollment of the 11 interventional ones that give a count, is the only one that started in 2026, is one of 11 with no phase, and was the 18th registered.
1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.
Browse Cerebral Palsy studies →8 of the 18 studies in Cerebral Palsy by IRCCS Eugenio Medea are open now, in 1 country. Recruiting first, the newest first:
IRCCS Eugenio Medea · Sites in Italy
Ages 4–80 · Healthy volunteers
IRCCS Eugenio Medea · Sites in Italy
Ages 8–17 · Healthy volunteers
IRCCS Eugenio Medea · Sites in Italy
Ages 5–17
IRCCS Eugenio Medea · Sites in Italy
Ages 36 mo–5 yrs
IRCCS Eugenio Medea · Sites in Italy
Ages 5–20
By country, each count listing its studies:
Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.
This study: 6 Years to 14 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
18 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 1 started in 2026.
This study's planned enrollment of 12 is below the median of 34 across 1,434 interventional studies indexed under Cerebral Palsy.
Median enrollment 44 across the 11 interventional studies, 59 across the 7 observational. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
IRCCS Eugenio Medea is the lead sponsor of 109 studies on the registry; 52 are open to participants now.
1 of the studies in Cerebral Palsy by IRCCS Eugenio Medea that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06622655IRCCS Eugenio MedeaClinical Improvement Due to the Home Use of Agilik in Children With Cerebral Palsy | 2026-11 |
Add it to your calendar (.ics) → With an account.
Among the 18 studies in Cerebral Palsy by IRCCS Eugenio Medea, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this pilot interventional study (pre-post design) is to learn if a co-designed wrist-hand orthosis can improve acceptability compared to a conventional orthosis in children aged 6 to 14 years with neuromotor disorders following acquired or congenital brain injury.
The main questions it aims to answer are:
Does a wrist-hand orthosis developed through a co-design process with the pediatric patient show greater acceptability - measured via the Technological Acceptance Measure (TAM-3) - compared to the conventional orthosis already used by the patient? Does the co-designed orthosis guarantee at least equivalent functional performance to the conventional orthosis, as assessed through upper limb kinematic analysis?
Researchers will compare the co-designed orthosis to the conventional orthosis to see if the co-design and personalization process improves acceptance, satisfaction, and functional outcomes.
Participants will:
Complete acceptance and satisfaction questionnaires (TAM-3 and QUEST 2.1) and undergo functional upper limb assessment while wearing their conventional orthosis Participate in two structured co-design workshops (\~1.5 hours each) involving creative and expressive activities to define preferences for their personalized orthosis Receive and wear the co-designed 3D-printed orthosis, then repeat functional assessments and questionnaires, and take part in a semi-structured interview about their co-design experience.
Background Pediatric upper limb orthoses are essential rehabilitative and assistive devices for children with musculoskeletal and neurological conditions, particularly those with neuromotor disorders resulting from acquired or congenital brain injury such as cerebral palsy. Despite technological advances in orthotic design, a fundamental challenge persists: most pediatric orthoses are adaptations of devices originally conceived for adults, often overlooking the specific physical characteristics and aesthetic needs of children. This approach can compromise device acceptability and, consequently, therapeutic efficacy.
Growing evidence highlights the critical role of aesthetic and psychosocial factors in assistive technology adoption. Children may refuse to use orthoses perceived as bulky, unattractive, or stigmatizing among peers. Social context and peer judgment significantly influence a child's perception and use of the device, potentially affecting self-image and psychosocial wellbeing.
Simultaneously, the literature emphasizes the benefits of co-design approaches and User-Centred Design (UCD) philosophy in assistive technology development. Active involvement of end users in the design process allows integration of their experiences, preferences, and emotions, leading to more accepted devices. This approach recognizes disability as an individual experience and aims to create a positive affective bond between the product and the user. Despite these recognized benefits, significant gaps remain in the literature specifically regarding pediatric upper limb orthoses: while co-design has been successfully applied in prosthetics for adults, analogous studies focused on the pediatric population are lacking.
Study Design This is a single-center, prospective, no-profit, pre-post interventional pilot study conducted at the IRCCS Eugenio Medea - "La Nostra Famiglia" Association, Bosisio Parini (LC), Italy.
All activities directly involving patients and caregivers are conducted at the Bosisio Parini site.
Intervention Details Phase 1 - Baseline Assessment (First Appointment)
Patients and their caregiver/tutor are separately administered two validated questionnaires assessing acceptability and satisfaction of the conventional orthosis currently in use:
A quantitative functional assessment of the upper limb is performed using a certified optoelectronic motion analysis system (BTS Bioengineering Smart DX). Participants perform standardized functional movements - including Hand-to-Mouth and Hit-to-Target (reach) - while wearing the conventional orthosis. A multivariate kinematic protocol developed and validated at IRCCS E. Medea is used to measure joint movements at the wrist, elbow, shoulder, and trunk.
At the end of the first appointment, participants receive a take-home activity kit to complete before the second appointment. This consists of two illustrated boards - one representing a school day, one a holiday - where children reconstruct their daily routine using stickers depicting both activities and emotions related to orthosis use, supplemented by brief written comments. Families photograph and send the completed boards to the researcher prior to the second appointment for preliminary analysis.
Phase 2 - Co-Design Sessions (Second and Third Appointments) Two structured co-design workshops are held on separate days at the Bosisio Parini site, each lasting approximately 1.5 hours, conducted in small groups of up to 7 children with their respective caregivers. A researcher acts as facilitator. Caregivers are present for communicative support only; clear rules ensure that parental involvement does not interfere with children's free expression.
First Workshop - Exploration of Latent Needs and Deep Meanings: Participants engage in play-based expressive activities using creative and non-verbal tools (LEGO blocks, persona cards, crafting materials, colored paper, collage, pencils) to surface lived experiences, aesthetic perceptions, and symbolic values related to their orthosis. Activities may include naming three things they love and three they dislike about their orthosis, or representing abstract concepts related to identity, comfort, visibility, or stigma. Insights gathered inform the design of the second workshop.
Second Workshop - Creative Personalization of the Orthosis: Participants design their "dream orthosis" using drawings, collage, decorative materials, colors, accessories, and 3D-printed orthosis prototypes. They may apply materials, add textures, symbolic elements, or representative accessories to give concrete form to their personalization wishes. The goal is to collect personalized visual inputs to guide the subsequent design and prototyping phase.
At the end of the second workshop, upper limb anatomy acquisition is performed using anthropometric measurements, 3D scanning, and if necessary, plaster casting. All methods aim to produce a digital model of the limb for the subsequent design phase. This step may be supported by technicians from Barbieri S.p.A. - Progettiamo Autonomia.
Orthosis Production The co-designed orthosis is produced at the Bosisio Parini site by the researcher. Following this, Barbieri S.p.A. orthopedic technicians finalize the device and issue the manufacturer's declaration of conformity pursuant to MDR 745/2017.
No costs are borne by the patient or the National Health Service; all costs related to orthosis production are covered by the Promoter.
Phase 3 - Post-Intervention Assessment (Fourth Appointment) The co-designed orthosis is delivered to the patient, who is asked to wear it for at least two hours at the Bosisio Parini site. A therapist then performs a functional assessment identical to that conducted at the first appointment, including VAS pain evaluation. The same TAM-3 and QUEST 2.1 questionnaires are re-administered to both patient and caregiver in separate settings to assess acceptability and satisfaction with the co-designed orthosis.
Additionally, a semi-structured interview with open-ended questions is conducted individually with both the child and the caregiver to explore four domains: (1) experience of the co-design process (enjoyment and engagement); (2) perception of the outcome (aesthetic, functional, and emotional satisfaction); (3) emotional experience during the process and orthosis use; (4) suggestions for future improvements. The interview follows a pre-established guide while allowing for free exploration, and is administered separately to child and caregiver to ensure independent expression.
Statistical Analysis Statistical analyses are conducted using IBM SPSS Statistics. Descriptive statistics are used throughout. Normality of continuous variables is assessed via the Shapiro-Wilk test; normally distributed variables are reported as mean ± standard deviation, non-normal variables as median and interquartile range. Categorical variables are described using absolute frequencies and percentages. TAM-3 and QUEST 2.1 scores for the conventional and co-designed orthoses are compared using descriptive effect estimates with 95% confidence intervals. Correlations between variables are explored descriptively or via Spearman non-parametric coefficients. No subgroup analyses are planned given the limited sample size.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: Orthosis acceptability
Participants will receive a personalized wrist-hand orthosis developed through a co-design process. During two structured workshops, children and caregivers express aesthetic preferences and personalization needs using creative tools (drawings, collage, 3D-printed prototypes). Upper limb anatomy is acquired via 3D scanning and/or anthropometric measurements. The orthosis is then digitally designed, 3D-printed with biocompatible materials using a multicolor FDM printer, finished manually, and certified as a custom medical device per MDR 745/2017. Participants evaluate the co-designed orthosis in terms of acceptability (TAM-3), satisfaction (QUEST 2.1), and upper limb functional performance (optoelectronic motion analysis), comparing outcomes with their conventional orthosis assessed at baseline.
Change in wrist-hand orthosis acceptability as measured by the Technological Acceptance Measure (TAM-3) score between first and last study visit
Orthosis acceptability is measured using the TAM-3, adapted for the pediatric population, evaluating 9 constructs across 27 items: perceived usefulness, perceived ease of use, self-efficacy, perception of external control, playfulness, anxiety, enjoyment, output quality, and behavioural intention. Each construct is scored as the mean of its items on a 5-point Likert scale (1 = strongly disagree to 5 = strongly agree); higher scores indicate greater acceptability, except for the anxiety subscale where lower scores indicate better outcome. The questionnaire is administered separately to the child and caregiver at baseline (conventional orthosis) and at the final visit (co-designed orthosis). Change from baseline is calculated as the difference between final and baseline scores for each subscale.
Time frame: Baseline and up to 12 months
Change in upper limb functional performance as measured by optoelectronic motion analysis between first and last study visit
Upper limb kinematics are assessed using a certified optoelectronic motion analysis system (BTS Bioengineering Smart DX). Participants perform standardized functional movements (Hand-to-Mouth and Hit-to-Target). Active Range of Motion (ROM) is measured at wrist, elbow, shoulder, and trunk. Qualitative observations of motor performance during functional tasks are also recorded. Assessment is performed with both the conventional and the co-designed orthosis.
Time frame: Baseline and up to 12 months
Patient and caregiver experience of the co-design process as assessed by semi-structured interview at final visit
A semi-structured interview with open-ended questions is conducted individually with the child and caregiver at the final visit. It explores four domains: (1) enjoyment and engagement in co-design activities; (2) aesthetic, functional, and emotional satisfaction with the final orthosis; (3) positive or negative emotions associated with the process and orthosis use; (4) suggestions for future improvements. Responses are qualitatively coded and analyzed descriptively.
Time frame: Up to 12 months
Plan to share: Yes — The results obtained at the end of this clinical trial will be presented at national and international conferences and submitted to peer-reviewed international journals. The raw data of the study will be published among the supplementary materials of scientific articles and/or uploaded to Zenodo, a multidisciplinary repository, managed by CERN in Geneva, which allows researchers to share and preserve research results in any size and form. Depositing data in ZENODO guarantees their compliance with the FAIR principles.
Supporting information: Study protocol, Statistical analysis plan
Started Jun 2026 (actual). Primary completion is estimated for Apr 2028, 22 months after the start.
Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 22 months is above that.
Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.